norgestimate has been researched along with Body Weight in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnowski, CE; Burkman, RT; Fisher, AC; LaGuardia, KD; Wan, GJ | 1 |
Taneepanichskul, S; Tantbirojn, P | 1 |
Knopp, RH; Leboeuf, RC; Rosenfeld, ME; Shultz, JM; Zhu, XD | 1 |
Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
Barnowski, C; Hampton, RM; Wan, GJ; Zhang, HF | 1 |
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
Anderson, FD | 1 |
Dain, MP; Janaud, A; Rouffy, J; Upmalis, D | 1 |
Kafrissen, ME | 1 |
1 review(s) available for norgestimate and Body Weight
Article | Year |
---|---|
Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
Topics: Acne Vulgaris; Animals; Body Weight; Carbohydrates; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Meta-Analysis as Topic; Norgestrel; Prolactin; Receptors, Androgen; Receptors, Progesterone; Sex Hormone-Binding Globulin | 1992 |
6 trial(s) available for norgestimate and Body Weight
Article | Year |
---|---|
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Pregnancy, Unplanned; Proportional Hazards Models; Retrospective Studies; Risk; Young Adult | 2009 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norgestrel; Retrospective Studies; Treatment Outcome | 2008 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel | 1992 |
2 other study(ies) available for norgestimate and Body Weight
Article | Year |
---|---|
Norgestimate and medroxyprogesterone acetate do not attenuate the atheroprotective effects of 17beta-estradiol in ovariectomized, apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Arteriosclerosis; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Estradiol; Female; Insulin; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Mice; Mice, Knockout; Norgestrel; Organ Size; Ovariectomy; Random Allocation; Sinus of Valsalva | 2004 |
A norgestimate-containing oral contraceptive: review of clinical studies.
Topics: Blood Coagulation; Body Weight; Carbohydrate Metabolism; Contraceptives, Oral; Endocrine Glands; Female; Humans; Lipids; Lipoproteins; Menstrual Cycle; Norgestrel | 1992 |